🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The role of prophylactic biliary stenting after complete clearance of commo...
Status
Completed
Location
National Liver Institute, Menoufia University, Egypt.
Start Date
2024-03-01
Trial ID
NCT07331142
Post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis (PEP...
Status
Completed
Location
Department of gastroenterology,Chinese PLA 174 Hospital
Start Date
2016-02
Trial ID
NCT02709421
BACKGROUND: The most common complication of endoscopic retrograde cholangio...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT02497872
Treatments Being Tested
This is a prospective, multicenter, open-label, randomized controlled trial...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07238296
Treatments Being Tested
Endoscopic retrograde cholangiopancreatography (ERCP) stands as the primary...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-01
Trial ID
NCT06550973
Treatments Being Tested
The purpose of this study is to determine if a procedure called Endoscopic ...
Status
Completed
Location
University of Arkansas for Medical Sciences
Start Date
2018-09-27
Trial ID
NCT03609944
Treatments Being Tested
This study is a prospective, randomized controlled trial designed to compar...
Status
Completed
Location
Wuhan No.1 Hospital (Wuhan Hospital of Traditional Chinese & Western Medicine)
Start Date
2021-05-01
Trial ID
NCT07064980
Treatments Being Tested
The goal of this clinical trial is to learn if endoscopic retrograde cholan...
Status
Unknown
Location
Changhai Hospital
Start Date
2024-07-01
Trial ID
NCT06364397
Treatments Being Tested
Endoscopic retrograde cholangiopancreatography (ERCP) is a key procedure fo...
Status
Completed
Location
Chihuahua City General Hospital "Dr. Salvador Zubirán Anchondo"
Start Date
2024-03-04
Trial ID
NCT07599605
Treatments Being Tested